IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomas
Abstract Pediatric high-grade gliomas (pHGG) and pediatric diffuse midline gliomas (pDMG) are devastating diseases without durable and curative options. Although targeted immunotherapy has shown promise, the field lacks immunocompetent animal models to study these processes in detail. To achieve thi...
Saved in:
| Main Authors: | M. Seblani, M. Zannikou, J. T. Duffy, T. Joshi, R. N. Levine, A. Thakur, M. Puigdelloses-Vallcorba, C. M. Horbinski, J. Miska, D. Hambardzumyan, O. J. Becher, Irina V. Balyasnikova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Acta Neuropathologica Communications |
| Online Access: | https://doi.org/10.1186/s40478-025-01991-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization of Traffic Flow by Allowing Private Cars to Merge into the Bus Lane at Specific Locations
by: Zhentao Yin, et al.
Published: (2024-01-01) -
Preliminary exploration of PSMA CAR-T combined with GD2 CAR-T for the treatment of refractory/relapsed gliomas
by: Jinshan Gu, et al.
Published: (2025-05-01) -
CAR-T cell therapy for the treatment of adult high-grade gliomas
by: Sangwoo Park, et al.
Published: (2024-12-01) -
Effects of preweaning milk allowance on long-term metabolism in Holstein heifers
by: L.N. Leal, et al.
Published: (2025-05-01) -
Pooled screening for CAR function identifies novel IL-13Rα2-targeted CARs for treatment of glioblastoma
by: Douglas A Lauffenburger, et al.
Published: (2025-02-01)